These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30819257)

  • 21. Effect of Serum Growth Differentiation Factor-15 and the Syntax Score on 2-Year Outcomes in Patients With Acute Coronary Syndrome.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P; Consuegra-Sanchez L
    Am J Cardiol; 2016 May; 117(10):1569-1574. PubMed ID: 27013387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding.
    Lindholm D; Hagström E; James SK; Becker RC; Cannon CP; Himmelmann A; Katus HA; Maurer G; López-Sendón JL; Steg PG; Storey RF; Siegbahn A; Wallentin L
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth differentiation factor 15 and coronary collateral formation.
    Sun T; Huang Y; Phillips MI; Luo X; Zhu J; Shi H; Li J
    Clin Cardiol; 2010 Jan; 33(1):E1-5. PubMed ID: 20014173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testosterone as a marker of coronary artery disease severity in middle aged males.
    Gururani K; Jose J; George PV
    Indian Heart J; 2016 Dec; 68 Suppl 3(Suppl 3):S16-S20. PubMed ID: 28038719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation.
    Akboga MK; Canpolat U; Sahinarslan A; Alsancak Y; Nurkoc S; Aras D; Aydogdu S; Abaci A
    Atherosclerosis; 2015 May; 240(1):110-4. PubMed ID: 25770689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of growth differentiation factor 15 with other key biomarkers, functional parameters and mortality in community-dwelling older adults.
    Rothenbacher D; Dallmeier D; Christow H; Koenig W; Denkinger M; Klenk J;
    Age Ageing; 2019 Jul; 48(4):541-546. PubMed ID: 30855645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth Differentiation Factor 15, Its 12-Month Relative Change, and Risk of Cardiovascular Events and Total Mortality in Patients with Stable Coronary Heart Disease: 10-Year Follow-up of the KAROLA Study.
    Dallmeier D; Brenner H; Mons U; Rottbauer W; Koenig W; Rothenbacher D
    Clin Chem; 2016 Jul; 62(7):982-92. PubMed ID: 27197673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GDF-15 (Growth Differentiation Factor 15) Is Associated With Lack of Ventricular Recovery and Mortality After Transcatheter Aortic Valve Replacement.
    Kim JB; Kobayashi Y; Moneghetti KJ; Brenner DA; O'Malley R; Schnittger I; Wu JC; Murtagh G; Beshiri A; Fischbein M; Miller DC; Liang D; Yeung AC; Haddad F; Fearon WF
    Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29222133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
    Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
    J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
    Koc M; Karaarslan O; Abali G; Batur MK
    Tex Heart Inst J; 2010; 37(1):42-8. PubMed ID: 20200626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
    Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
    Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.
    Mostowik M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Gajos G
    Adv Clin Exp Med; 2015; 24(6):979-85. PubMed ID: 26771969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective.
    Adela R; Banerjee SK
    J Diabetes Res; 2015; 2015():490842. PubMed ID: 26273671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
    Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
    Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study.
    Andersson C; Enserro D; Sullivan L; Wang TJ; Januzzi JL; Benjamin EJ; Vita JA; Hamburg NM; Larson MG; Mitchell GF; Vasan RS
    Atherosclerosis; 2016 May; 248():245-51. PubMed ID: 26972631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of growth differentiation factor-15 are associated with myocardial injury in patients undergoing off-pump coronary artery bypass grafting.
    Yuan Z; Li H; Qi Q; Gong W; Qian C; Dong R; Zang Y; Li J; Zhou M; Cai J; Wang Z; Chen A; Ye X; Zhao Q
    Sci Rep; 2016 Jun; 6():28221. PubMed ID: 27311391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth differentiation factor-15 levels and the risk of contrast induced acute kidney injury in acute myocardial infarction patients treated invasively: A propensity-score match analysis.
    Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
    PLoS One; 2018; 13(3):e0194152. PubMed ID: 29529072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between growth differentiation factor-15 and the severity of chronic heart failure in patients with coronary atherosclerosis.
    Du H; Yang L; Zhang H; Zhang XL; Shao HY
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12844-12848. PubMed ID: 33378034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.